 |
Viatris
VTRS
|
$ 15.04
|
18.1 B
|
$ 172 M
|
-5.2
|
1.2
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 6.16
|
3.81 B
|
$ -105 M
|
-0.6
|
4.7
|
$ -10.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 5.65
|
2.06 B
|
$ 3.23 B
|
-5.2
|
0.2
|
$ -1.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 11.92
|
1.65 B
|
$ 579 M
|
-56.4
|
0.4
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 40.9
|
1.5 B
|
$ 17.6 M
|
-90.1
|
6.4
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.64
|
1.36 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 24.44
|
1.13 B
|
$ 86.2 M
|
141.6
|
1.7
|
$ 0.2
|
 |
 |
Solid Biosciences
SLDB
|
$ 7.13
|
624 M
|
$ -115 M
|
-3.2
|
32.2
|
$ -2.3
|
 |
 |
Emergent BioSolutions
EBS
|
$ 8.47
|
434 M
|
$ -238 M
|
-1.1
|
0.4
|
$ -7.5
|
 |
 |
Evolus
EOLS
|
$ 5.33
|
344 M
|
$ -48.4 M
|
-4.9
|
1.3
|
$ -1.1
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 2.57
|
338 M
|
$ 2.42 M
|
-33.6
|
0.7
|
$ -0.1
|
 |
 |
Veru
VERU
|
$ 2.26
|
305 M
|
$ -31.2 M
|
-1.6
|
22.4
|
$ -1.4
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 7.64
|
302 M
|
$ -165 M
|
-3.9
|
-277.2
|
$ -1.9
|
 |
 |
Assertio Holdings
ASRT
|
$ 18.47
|
118 M
|
$ -3.27 M
|
-83.8
|
0.9
|
$ -0.2
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.36
|
61.3 M
|
$ 1.01 M
|
-20.0
|
1.5
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.99
|
49.4 M
|
$ -72.9 M
|
-1.9
|
17.8
|
$ -0.5
|
 |
 |
Rockwell Medical
RMTI
|
$ 0.89
|
32 M
|
$ 1.12 M
|
-22.0
|
0.4
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.07
|
23.9 M
|
$ -3.18 M
|
-40.8
|
8.8
|
$ -0.0
|
 |
 |
cbdMD
YCBD
|
$ 0.87
|
3.75 M
|
$ -1.22 M
|
-0.2
|
0.2
|
$ -3.9
|
 |
 |
China Pharma Holdings
CPHI
|
$ 0.53
|
2.27 M
|
$ -1.98 M
|
-0.4
|
0.6
|
$ -1.2
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 1.2
|
1.49 M
|
$ -5.22 M
|
-0.5
|
0.1
|
$ -2.2
|
 |